Feeds:
Posts
Comments

Posts Tagged ‘U.S. Food and Drug Administration’

WALL ST JOURNAL: The US Food and Drug Administration has approved Jevtana, a chemotherapy drug used in combination with the steroid prednisone to treat men with advanced prostate cancer. READ MORE> and HERE>

Read Full Post »

REUTERS: The US Food and Drug Administration has approved the sale of Amgen Inc’s osteoporosis drug Prolia – denosumab – to help prevent fractures in advanced cancer patients just days after the medicine received European approval. It will cost $US825 per 60 milligram injection. READ MORE>

Read Full Post »

JULY 16: URO TODAY: Circulating tumour cells have been recently accepted by the US Food and Drug Administration  as a prognostic tool in advanced prostate cancer. However, a number of questions remain about the use of the test. READ MORE>

Read Full Post »

JULY 8: VITABEAT.COM: The US Food and Drug Administration has approved the generic version of prostate cancer drug Casodex manufactured by AstraZeneca. The drug checks the growth of prostate cancer by controlling the actions of the male hormone androgen. READ MORE>

Read Full Post »

JUNE 11: SEEKING ALPHA.COM: A groundbreaking new treatment for prostate cancer, Provenge, will likely receive US Food and Drug Administration approval and become widely available just as the first Baby Boomers reach 65 in 2010.  READ MORE>

Read Full Post »

MAY 14: MEMPHIS DAILY NEWS:  Memphis company GTx expects to receive approval from the US Food and Drug Administration on Octopber 30 to begin selling a drug to prevent bone fractures in men undergoing hormone therapy to treat bone cancer. The company also has other drugs in the pipeline related to the prevention and treatment of prostate cancer and to build body mass in people with cancer-induced muscle loss. READ MORE>

Read Full Post »

REUTERS:  OFFICIAL  approval is a step closer in the US for the first cancer immunotherapy –  a drug to fight cancer by stimulating the immune system to attack cancer cells – after the latest trials on more than 500 men with late-stage prostate cancer. READ MORE>

Read Full Post »